Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Queensland Health
Farmers Insurance
Baxter
Healthtrust
Dow
Medtronic
Cerilliant

Generated: December 11, 2018

DrugPatentWatch Database Preview

Indium in-111 chloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for indium in-111 chloride and what is the scope of indium in-111 chloride patent protection?

Indium in-111 chloride is the generic ingredient in two branded drugs marketed by Ge Healthcare and Mallinkrodt Nuclear, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for indium in-111 chloride. Two suppliers are listed for this compound.

Summary for indium in-111 chloride
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 23
Suppliers / Packagers: 2
Bulk Api Vendors: 1
DailyMed Link:indium in-111 chloride at DailyMed

US Patents and Regulatory Information for indium in-111 chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare INDICLOR indium in-111 chloride INJECTABLE;INJECTION 019862-001 Dec 29, 1992 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mallinkrodt Nuclear INDIUM IN 111 CHLORIDE indium in-111 chloride INJECTABLE;INJECTION 019841-001 Sep 27, 1994 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cerilliant
Chinese Patent Office
Julphar
QuintilesIMS
UBS
Dow
McKesson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.